Home 5 Clinical Diagnostics Insider 5 Companion Diagnostics Driving New Model for Pharma-Dx Partnerships

Companion Diagnostics Driving New Model for Pharma-Dx Partnerships

by | Aug 17, 2017 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Top of the News-dtet

US oncology patients are missing out on targeted therapies due to a combination of testing "quality gaps" and slow test diffusion

Sign up for our free weekly Lab & Pathology Insider email newsletter

Subscribe to Clinical Diagnostics Insider to view

Start a Free Trial for immediate access to this article